Durable responses to immunotherapy seen in rare angiosarcoma tumors
In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded
Read more
In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded
Read moreAs human beings age, the functioning of organs gradually deteriorates. While countless past studies have investigated the effects of aging
Read moreDelayed immune responses may make COVID-19 more deadly for elderly people – and it may kill more men because their
Read moreAn experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read moreSocial support can change the way we perceive an unpleasant situation, but some types of support seem more effective than
Read moreA therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head
Read more